GENERAL ENQUIRIES: Tel: + 27 12 841 2911 | Email: callcentre@csir.co.za

Show simple item record

dc.contributor.author Lemmer, Yolandy
dc.contributor.author Thanyani, ST
dc.contributor.author Vrey, PJ
dc.contributor.author Driver, CHS
dc.contributor.author Venter, L
dc.contributor.author Van Wyngaardt, S
dc.contributor.author Ten Bokum, AMC
dc.contributor.author Ozoemena, KI
dc.contributor.author Pilcher, LA
dc.contributor.author Fernig, DG
dc.contributor.author Stoltz, AC
dc.contributor.author Swai, HS
dc.contributor.author Verschoor, JA
dc.date.accessioned 2011-05-05T12:36:16Z
dc.date.available 2011-05-05T12:36:16Z
dc.date.issued 2009
dc.identifier.citation Lemmer, Y, Thanyani, ST, Vrey, PJ et al. 2009. Detection of antimycolic acid antibodies by liposomal biosensors. Methods in Enzymology, Vol. 464(Part F), pp 79-102 en_US
dc.identifier.issn 0076-6879
dc.identifier.uri http://www.ncbi.nlm.nih.gov/pubmed/19903551
dc.identifier.uri http://hdl.handle.net/10204/4983
dc.description Copyright: 2010 Elsevier. This is the pre print version of the work. The definitve version is published Methods in Enzymology, Vol. 464(Part F), pp 79-102 en_US
dc.description.abstract Antibodies to mycolic acid (MA) antigens can be detected as surrogate markers of active tuberculosis (TB) with evanescent field biosensors where the lipid antigens are encapsulated in liposomes. Standard immunoassay such as ELISA, where the lipid antigen is not encapsulated, but directly adsorbed to the wellbottoms of microtiter plates, does not yield the required sensitivity and specificity for accurate diagnosis of TB. One reason for this is the cross-reactivity of natural anticholesterol antibodies with MAs. MAs are the major cell wall lipids of mycobacteria. Mycobacterial MA has immunomodulatory properties and elicits specific antibodies in TB patients. Liposomes were optimized for their use as carriers both for the presentation of immobilized purified mycobacterial MA on sensor surfaces, and as a soluble inhibitor of antibody binding in inhibition assays. By using an inhibition assay in the biosensor, the interference by anticholesterol antibodies is reduced. Here, we describe the MA carrying capacity of liposomes with and without cholesterol as a stabilizing agent, optimized concentration and size of liposomes for use in the biosensor assay, comparison of the methods for wave-guide and surface plasmon resonance biosensors and how the cholesteroid nature of MA can be demonstrated by the biosensor when Amphotericin B is allowed to bind to MA in liposomes. en_US
dc.language.iso en en_US
dc.publisher Elsevier en_US
dc.relation.ispartofseries Workflow request;3553
dc.subject Mycolic acid en_US
dc.subject Tuberculosis en_US
dc.subject Liposomes en_US
dc.subject Mycobacterial en_US
dc.subject Enzymology en_US
dc.subject Biochemistry en_US
dc.title Detection of antimycolic acid antibodies by liposomal biosensors en_US
dc.type Article en_US


Files in this item

This item appears in the following Collection(s)

Show simple item record

Search ResearchSpace


Advanced Search

Browse

My Account